KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Raw Materials (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Raw Materials for 8 consecutive years, with $23.7 million as the latest value for Q1 2023.

  • Quarterly Raw Materials rose 42.37% to $23.7 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $23.7 million through Mar 2023, up 42.37% year-over-year, with the annual reading at $21.0 million for FY2022, 21.44% up from the prior year.
  • Raw Materials for Q1 2023 was $23.7 million at Biolife Solutions, up from $21.0 million in the prior quarter.
  • The five-year high for Raw Materials was $23.7 million in Q1 2023, with the low at $1.3 million in Q3 2019.
  • Average Raw Materials over 5 years is $10.3 million, with a median of $7.5 million recorded in 2020.
  • Peak annual rise in Raw Materials hit 504.27% in 2021, while the deepest fall reached 6.12% in 2021.
  • Over 5 years, Raw Materials stood at $3.0 million in 2019, then dropped by 4.16% to $2.9 million in 2020, then skyrocketed by 504.27% to $17.3 million in 2021, then rose by 21.44% to $21.0 million in 2022, then rose by 13.04% to $23.7 million in 2023.
  • According to Business Quant data, Raw Materials over the past three periods came in at $23.7 million, $21.0 million, and $18.2 million for Q1 2023, Q4 2022, and Q3 2022 respectively.